Cargando…
Women's attitude towards prenatal screening for red blood cell antibodies, other than RhD
BACKGROUND: Since July 1998 all Dutch women (± 200,000/y) are screened for red cell antibodies, other than anti-RhesusD (RhD) in the first trimester of pregnancy, to facilitate timely treatment of pregnancies at risk for hemolytic disease of the fetus and newborn (HDFN). Evidence for benefits, conse...
Autores principales: | Koelewijn, JM, Vrijkotte, TGM, de Haas, M, van der Schoot, CE, Bonsel, GJ |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605433/ https://www.ncbi.nlm.nih.gov/pubmed/19014424 http://dx.doi.org/10.1186/1471-2393-8-49 |
Ejemplares similares
-
Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis
por: Koelewijn, JM, et al.
Publicado: (2009) -
Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study
por: Slootweg, Y. M., et al.
Publicado: (2022) -
Single-strained DNA aptamers mask RhD antigenic epitopes on human RhD(+) red blood cells to escape alloanti-RhD immunological recognition
por: Zhang, Yinze, et al.
Publicado: (2020) -
Diagnostic performance of the noninvasive prenatal FetoGnost RhD assay for the prediction of the fetal RhD blood group status
por: Legler, Tobias J., et al.
Publicado: (2021) -
RHD exon 5, 7 and 10 targeted non-invasive prenatal screening of fetal Rhesus-D (RhD) in selected RhD negative pregnant women in Ethiopia
por: Niguse, Birhanu, et al.
Publicado: (2022)